Showing all 2 results
Divalproex Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.
Active Ingredient Strength Primary Clinical Function Divalproex Sodium USP/Ph.Eur. 250 mg (DR / ER) The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy. Divalproex Sodium USP/Ph.Eur. 500 mg (DR / ER) The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania. Excipients (Enteric DR Formulation) Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).
Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
